化学
药物发现
优先次序
计算生物学
注释
代谢组学
规范化(社会学)
中医药
计算机科学
系统生物学
限制
鉴定(生物学)
化学空间
药物靶点
可扩展性
分类
天然产物
系统药理学
仿形(计算机编程)
模块化设计
解码方法
数据库规范化
化学数据库
可解释性
化学生物学
化学信息学
作者
Xingyi Liang,Yixin Cui,Yadi Tan,Yang Zhou,Xingzu Cao,Zhe Wu,Chunling Feng,Xiaodong Wen,Xudong Xing,Hua Yang
标识
DOI:10.1021/acs.analchem.5c04126
摘要
Despite decades of pharmacological interest, the systematic identification of bioactive compounds in natural products (NPs) and traditional Chinese medicines (TCMs) remains constrained by the chemical complexity of herbal formulations and the absence of scalable tools to link chemical features with functional phenotypes. The field of drug discovery based on TCMs is a complex area of research that necessitates robust analytical platforms. While untargeted mass spectrometry enables the high-throughput profiling of molecular constituents, and high-content imaging captures multiparametric cellular responses, these data sets remain largely disconnected, limiting their translational utility. To address this gap, we developed AnnoTCM, an open-access platform integrating high-content cell phenotypic screening with untargeted metabolomics to systematically annotate pharmacologically active ions in TCMZ-score normalization and cluster correlation. To validate the utility of the platform, we employed Baoyuan Decoction (BYD), a classical antiaging traditional Chinese medicine formula. Using BYD, we constructed a database comprising 48 448 ions and associated phenotypic profiles derived from inflammation- and senescence-relevant models. Through the scoring and categorization of active ions, we identified 16 active compounds, including apigenin-7-O-glucoside and ginsenoside Rg1. These compounds were subsequently validated experimentally. Collectively, these findings demonstrate that AnnoTCM provides a generalizable, function-oriented platform for compound prioritization in TCMs research. This platform supports data-driven pharmacological studies and facilitates early-stage drug discovery from natural products.
科研通智能强力驱动
Strongly Powered by AbleSci AI